What is APOE4? A plain-language primer
APOE4 is the most common genetic risk factor for late-onset Alzheimer’s. Here’s what the gene does, what carrying it means, and what it doesn’t mean.
Updated May 20, 2026 7 min read
Deep Dives
Understand APOE4, and what to do about it
Long-form, carefully sourced guides that translate the research into clear, practical steps. Browse by topic below.
APOE4 Basics
View all →The APOE genotypes explained: from 2/2 to 4/4
You inherit one APOE allele from each parent. Here’s what each of the six combinations, from protective 2/2 to higher-risk 4/4, actually means.
Updated June 2, 2026 6 min read
How to get tested for APOE4, and whether you should
Consumer kits, clinical tests, and genetic counseling compared, plus the psychological and practical trade-offs of learning your APOE status.
Updated June 2, 2026 6 min read
Brain & Cognition
View all →APOE4 and Alzheimer’s risk: what the numbers actually mean
Relative risk, absolute risk, and age of onset: how to read the scary statistics about APOE4 and Alzheimer’s without losing perspective.
Updated May 22, 2026 8 min read
How APOE4 affects the brain
APOE4 influences how the brain clears amyloid, handles lipids, and manages inflammation. A plain-language tour of the leading mechanisms and what’s still uncertain.
Updated June 2, 2026 7 min read
APOE4, women, and sex differences in risk
Evidence suggests APOE4 may carry a different risk profile for women than men, especially at certain ages. Here’s what the research shows, and its limits.
Updated June 2, 2026 6 min read
Heart & Vascular
View all →APOE4, cholesterol, and cardiovascular risk
APOE4 does not only affect the brain. It shapes how your body handles cholesterol, which makes cardiovascular health a highly actionable lever for carriers.
Updated May 24, 2026 7 min read
ApoB vs. LDL-C: the number to actually watch
Standard cholesterol panels report LDL-C, but ApoB may better capture the particles that drive artery disease. What the distinction means for APOE4 carriers.
Updated June 2, 2026 6 min read
Blood pressure and brain health
High blood pressure is one of the best-established modifiable risk factors for dementia. Why it matters for APOE4 carriers, and how to keep it in range.
Updated June 2, 2026 6 min read
Diet & Nutrition
View all →APOE4 and saturated fat: the ongoing debate
One of the most argued-about questions for carriers. What is reasonably established, what stays uncertain, and how to think about it.
Updated May 28, 2026 7 min read
The Mediterranean and MIND diets: what the evidence shows
Two dietary patterns dominate the brain-health conversation. What the research actually supports, and how to apply it as an APOE4 carrier.
Updated June 2, 2026 7 min read
Omega-3s, DHA, and the APOE4 wrinkle
Omega-3 fats matter for the brain, but the evidence in APOE4 carriers has a twist. What is known, what is uncertain, and a measured approach.
Updated June 2, 2026 6 min read
Exercise & Fitness
View all →Exercise and APOE4: the strongest lever you control
Of all the modifiable factors, physical activity has some of the most consistent evidence for brain and cardiovascular health, and carriers may benefit especially.
Updated May 26, 2026 6 min read
Aerobic vs. strength training: what to do and how much
You need both. A practical guide to combining cardio and resistance training for brain, heart, and metabolic health, with sensible weekly targets.
Updated June 2, 2026 6 min read
Zone 2, VO₂max, and the longevity case for cardio
Two fitness ideas have jumped from the lab to the podcast circuit. What zone 2 and VO₂max really mean, and why cardiorespiratory fitness is worth the hype.
Updated June 2, 2026 6 min read
Sleep & Stress
View all →Sleep, the glymphatic system, and APOE4
Why sleep keeps coming up in Alzheimer’s research, what the glymphatic system is, and practical sleep priorities for carriers.
Updated May 30, 2026 5 min read
Sleep apnea and cognitive risk: the underdiagnosed lever
Obstructive sleep apnea is common, often silent, harmful to the brain and heart, and very treatable. Why it deserves attention from APOE4 carriers.
Updated June 2, 2026 6 min read
Stress, cortisol, and the brain
Chronic stress touches blood pressure, sleep, and behavior in ways that matter for brain health. Practical, evidence-aligned ways to manage it.
Updated June 2, 2026 5 min read
Latest Research
View all →Anti-amyloid drugs (lecanemab, donanemab) and what they mean for carriers
A new class of Alzheimer’s drugs can modestly slow decline, but APOE4 carriers, especially those with two copies, face higher rates of a key side effect.
Updated June 2, 2026 7 min read
The FINGER trial: can lifestyle change the trajectory?
The landmark FINGER study tested whether a combined lifestyle program could protect cognition in at-risk older adults. What it found, and why it matters for carriers.
Updated June 2, 2026 6 min read
Blood-based biomarkers for Alzheimer’s: the coming shift
For years, confirming Alzheimer’s biology meant a spinal tap or a PET scan. Blood tests are starting to change that, with big implications and real caveats.
Updated June 2, 2026 6 min read